Literature DB >> 21562372

A report of quality improvement in the care of patients with acute coronary syndromes.

Christopher P Cannon1, James W Hoekstra, David M Larson, Rachel Bongiorno Karcher, William A Mencia, Carolyn A Berry, Stephanie A Stowell.   

Abstract

Despite the existence and wide acceptance of guidelines for the treatment of patients with acute coronary syndromes, gaps in patient care still remain. To improve clinical processes of acute coronary syndromes care, a performance improvement (PI) continuing medical education (CME) program, a CME format approved by the American Medical Association, was developed. Clinician participants underwent a 3-stage process: (1) an initial patient chart review for self-assessment purposes, (2) the development and implementation of a personalized PI plan focusing on strategies to enhance processes of care, and (3) a second patient chart review to assess the changes in practice. Although participants provided a high baseline level of guideline-recommended care, there was an improvement in the documentation of the use of risk scores and a trend towards improved treatment times including many participants reaching a door-to-needle time of within 30 minutes. Participants were also more likely to measure cardiac biomarkers and document electrocardiogram performance times. These results demonstrate that PI is a valid and effective means of CME that has the potential to positively affect patient outcomes.

Entities:  

Mesh:

Year:  2011        PMID: 21562372     DOI: 10.1097/HPC.0b013e318204eb8b

Source DB:  PubMed          Journal:  Crit Pathw Cardiol        ISSN: 1535-2811


  8 in total

1.  Impact of Performance-Improvement Strategies on the Clinical Care and Outcomes of Patients With Type 2 Diabetes.

Authors:  Stephanie A Stowell; Howard B A Baum; Carolyn A Berry; Bianca R Perri; Liza King; Tod Mijanovich; Stephanie Albert; Sara C Miller
Journal:  Clin Diabetes       Date:  2014-01

2.  A clinician performance initiative to improve quality of care for patients with osteoporosis.

Authors:  Susan L Greenspan; John P Bilezikian; Nelson B Watts; Carolyn A Berry; William A Mencia; Stephanie A Stowell; Rachel Bongiorno Karcher
Journal:  J Womens Health (Larchmt)       Date:  2013-09-06       Impact factor: 2.681

3.  Implementation of a performance improvement initiative in colorectal cancer care.

Authors:  John L Marshall; Thomas H Cartwright; Carolyn A Berry; Stephanie A Stowell; Sara C Miller
Journal:  J Oncol Pract       Date:  2012-05-15       Impact factor: 3.840

4.  Enhancing the quality of care for patients with multiple sclerosis through performance improvement CME.

Authors:  Bruce A Cohen; Ben W Thrower; Carolyn A Berry; Stephanie A Stowell; William A Mencia; Rachel B Karcher
Journal:  Neurol Clin Pract       Date:  2013-06

5.  Monitoring guideline adherence in the management of acute coronary syndrome in hospitals: design of a multicentre study.

Authors:  J Tra; J Engel; I van der Wulp; M C de Bruijne; C Wagner
Journal:  Neth Heart J       Date:  2014-08       Impact factor: 2.380

Review 6.  Adherence to Cardiac Practice Guidelines in the Management of Non-ST-Elevation Acute Coronary Syndromes: A Systematic Literature Review.

Authors:  Josien Engel; Nikki L Damen; Ineke van der Wulp; Martine C de Bruijne; Cordula Wagner
Journal:  Curr Cardiol Rev       Date:  2017

7.  Understanding factors that influence the use of risk scoring instruments in the management of patients with unstable angina or non-ST-elevation myocardial infarction in the Netherlands: a qualitative study of health care practitioners' perceptions.

Authors:  Josien Engel; Marie-Julie Heeren; Ineke van der Wulp; Martine C de Bruijne; Cordula Wagner
Journal:  BMC Health Serv Res       Date:  2014-09-22       Impact factor: 2.655

8.  A cross-sectional multicentre study of cardiac risk score use in the management of unstable angina and non-ST-elevation myocardial infarction.

Authors:  Josien Engel; Ineke van der Wulp; Martine de Bruijne; Cordula Wagner
Journal:  BMJ Open       Date:  2015-11-24       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.